LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE 74th Regular Session April 17, 1995 TO: Honorable Hugo Berlanga, Chair IN RE: House Bill No. 2838 Committee on Public Health By: Maxey House of Representatives Austin, Texas FROM: John Keel, Director In response to your request for a Fiscal Note on House Bill No. 2838 (Relating to the powers and duties of the Texas Department of Health under the Texas Food, Drug, and Cosmetic Act.) this office has determined the following: The bill would modify provisions in the Texas Food, Drug, and Cosmetic Act. The definition of "manufacture" would be modified to exclude foods, drugs, and devices manufactured only for retail distribution. As a result, the Department of Health estimates the loss of fee revenue noted below. The reduction in expenditures would be associated with the reduction in regulatory activity. The probable fiscal implication of implementing the provisions of the bill during each of the first five years following passage is estimated as follows: Fiscal Probable Savings Probable Revenue Change in Year to General Loss from General Number of State Revenue Fund 001 Revenue Fund 001 Employees from FY 1995 1996 $1,123,323 $1,123,323 (20.0) 1997 1,123,323 1,123,323 (20.0) 1998 1,123,323 1,123,323 (20.0) 1999 1,123,323 1,123,323 (20.0) 2000 1,123,323 1,123,232 (20.0) Similar annual fiscal implications would continue as long as the provisions of the bill are in effect. No fiscal implication to units of local government is anticipated. Source: Department of Health LBB Staff: JK, KF, DF